Hepatitis A Vaccine Sales Market will reach 760 million US$ by the end of 2025

This report studies the global Hepatitis A Vaccine market status and forecast, categorizes the global Hepatitis A Vaccine market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year.

Two types of HAV vaccines are currently available internationally:

1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 years, and in adult dose (1 ml).

2. Live attenuated vaccines (based on H2 or LA-1 HAV strains): These vaccines are manufactured and used mainly in China and sporadically in the private sector in India.

Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year.

The classification of Hepatitis A Vaccine includes Inactivated Vaccine, Live Attenuated Vaccine, and the sales proportion of Inactivated Vaccine in 2017 is about 70.8%, and the proportion is increasing trend from 2013 to 2018.

Inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 years, and in adult dose (1 ml).

The global Hepatitis A Vaccine market is valued at 650 million US$ in 2017 and will reach 760 million US$ by the end of 2025, growing at a CAGR of 2.1% during 2018-2025.

Request Sample Copy of the Report @ https://www.qyresearch.com/sample-form/form/17088/global-hepatitis-a-vaccine-sales-market

The major players covered in this report

    GSK

    Merck

    Sanofi

    Sinovac

    Zhejiang Pukang

    Changchun Institute of Biological

    Kaketsuken

    IMBCA

    ChangSheng

    Convac

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering

    United States

    Europe

    China

    Japan

    Southeast Asia

    India

Ask for Discount on Research Report@ https://www.qyresearch.com/request-discount/form/17088/global-hepatitis-a-vaccine-sales-market